Computational modeling of interacting VEGF and soluble VEGF receptor concentration gradients

Frontiers in Physiology

Volumn 2 OCT, Issue , 2011, Pages

  Hashambhoy, Yasmin L ^a,b   Chappell, John C ^c   Peirce, Shayn M ^d   Bautch, Victoria L ^c,e   Mac Gabhann, Feilim ^a,b  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Angiogenesis; Capillary sprouting; Computational model; Mathematical model; Sflt 1; Vascular development; VEGF

Indexed keywords

EID: 84859858720     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00062     Document Type: Article

References (57)

1. Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., Kliche, S., Fellbrich, G., Ballmer-Hofer, K., Maglione, D., Mayr-Beyrle, U., Dewerchin, M., Dombrowski, S., Stanimirovic, D., Van Hummelen, P., Dehio, C., Hicklin, D. J., Persico, G., Herbert, J. M., Communi, D., Shibuya, M., Collen, D., Conway, E. M., and Carmeliet, P. (2003). Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9, 936-943.
2. Bailey, A. M., Lawrence, M. B., Shang, H., Katz, A. J., and Peirce, S. M. (2009). Agent-based model of therapeutic adipose-derived stromal cell trafficking during ischemia predicts ability to roll on P-selectin. PLoS Comput Biol. 5, e1000294. doi: 10.1371/journal.pcbi.1000294
3. Bailey, A. M., Thorne, B. C., and Peirce, S. M. (2007). Multi-cell agent-based simulation of the microvasculature to study the dynamics of circulating inflammatory cell trafficking. Ann. Biomed. Eng. 35, 916-936.
4. Bauer, A. L., Jackson, T. L., and Jiang, Y. (2007). A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. Biophys. J. 92, 3105-3121.
5. Bautch, V.L., Redick, S. D., Scalia, A., Harmaty, M., Carmeliet, P., and Rapoport, R. (2000). Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A. Blood 95, 1979-1987.
6. Bentley, K., Gerhardt, H., and Bates, P. A. (2008). Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation. J. Theor. Biol. 250,25-36.
7. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
8. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., Scholz, D., Acker, T., DiPalma, T., Dewerchin, M., Noel, A., Stalmans, I., Barra, A., Blacher, S., Vandendriessche, T., Ponten, A., Eriksson, U., Plate, K. H., Foidart, J. M., Schaper, W., Charnock-Jones, D. S., Hicklin, D. J., Herbert, J. M., and Collen, D., Persico, M. G. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-783.
9. Carmeliet, P., Ng, Y. S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., Perriard, J. C., Dewerchin, M., Flameng, W., Nagy, A., Lupu, F., Moons, L., Collen, D., D'Amore, P. A., and Shima, D. T. (1999). Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5, 495-502.
10. Chappell, J. C., Taylor, S. M., Ferrara, N., and Bautch, V L. (2009). Local guidance of emerging vessel sprouts requires soluble Flt- 1. Dev. Cell 17, 377-386.
11. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
12. Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.
13. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDRactivation.J. Biol. Chem. 273, 30336-30343.
14. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., and Betsholtz, C. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177.
15. Hellstrom, M., Phng, L. K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A. K., Karlsson, L., Gaiano, N., Yoon, K., Rossant, J., Iruela-Arispe, M. L., Kalén, M., Gerhardt, H., and Betsholtz, C. (2007). Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776-780.
16. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., and Shibuya, M. (1998). Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 95, 9349-9354.
17. Huang, K., Andersson, C., Roomans, G. M., Ito, N., and Claesson-Welsh, L. (2001). Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. Int. J. Biochem. Cell Biol. 33, 315-324.
18. Jakobsson, L., Franco, C. A., Bentley, K., Collins, R. T., Ponsioen, B., Aspalter, I. M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A., Schulte-Merker, S., and Gerhardt, H. (2010). Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 12, 943-953.
19. Ji, J. W., Mac Gabhann, F., and Popel, A. S. (2007). Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. Am. J. Physiol. Heart Circ. Physiol. 293, H3740-H3749.
20. Kappas, N.C., Zeng, G., Chappell, J. C., Kearney, J. B., Hazarika, S., Kallianos, K. G., Patterson, C., Annex, B. H., and Bautch, V L. (2008). The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J. Cell Biol. 181, 847-858.
21. Kearney, J. B., Ambler, C. A., Monaco, K. A., Johnson, N., Rapoport, R. G., and Bautch, V L. (2002). Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood 99, 2397-2407.
22. Kearney, J. B., and Bautch, V L. (2003). In vitro differentiation of mouse ES cells: hematopoietic and vascular development. Meth. Enzymol. 365, 83-98.
23. Kearney, J. B., Kappas, N. C., Ellerstrom, C., Di Paola, E W., and Bautch, V. L. (2004). The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood 103, 4527-4535.
24. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.
25. Lawson, N. D., Vogel, A. M., and Weinstein, B. M. (2002). Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3, 127-136.
26. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
27. Levine, H. A., Tucker, A. L., and Nilsen-Hamilton, M. (2002). A mathematical model for the role of cell signal transduction in the initiation and inhibition of angiogenesis. Growth Factors 20, 155-175.
28. Mac Gabhann, F., Ji, J. W., and Popel, A. S. (2006). Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy. PLoS Comput. Biol. 2, e127. doi: 10.1371/journal.pcbi.0020127
29. Mac Gabhann, F., Ji, J. W., and Popel, A. S. (2007). VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle. J. Appl. Physiol. 102, 722-734.
30. Mac Gabhann, F., and Popel, A. S. (2005). Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model. Am. J. Physiol. Heart Circ. Physiol. 288, H2851-H2860.
31. Mac Gabhann, F., and Popel, A. S. (2007a). Dimerization of VEGF receptors and implications for signal transduction: a computational study. Biophys. Chem. 128, 125-139.
32. Mac Gabhann, F., and Popel, A. S. (2007b). Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 292, H459-H474.
33. Mac Gabhann, F., and Popel, A. S. (2008). Systems biology of vascular endothelial growth factors. Microcirculation 15, 715-738.
34. McDougall, S. R., Anderson, A. R., and Chaplain, M. A. (2006). Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J. Theor. Biol. 241, 564-589.
35. Miquerol, L., Langille, B. L., and Nagy, A. (2000). Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127, 3941-3946.
36. Nilsson, I., Bahrain, E, Li, X., Gualandi, L., Koch, S., Jarvius,M.,Söderberg, O., Anisimov, A., Kholová, I., Pytowski, B., Baldwin, M., Yläherttuala, S., Alitalo, K., Kreuger, J., and Claesson-Welsh, L. (2010). VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J. 29, 1377-1388.
37. Olsson, A.-K., Dimberg, A., Kreuger, J., and Claesson-Welsh, L. (2006). VEGF receptor signalling? In control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371.
38. Park, M., and Lee, S. T. (1999). The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site. Biochem. Biophys. Res. Commun. 264, 730-734.
39. Peirce, S. M. (2008). Computational and mathematical modeling of angiogenesis. Microcirculation 15, 739-751.
40. Peirce, S. M., Van Gieson, E. J., and Skalak, T. C. (2004). Multicellular simulation predicts microvascular patterning and in silico tissue assembly. FASEB J. 18, 731-733.
41. Qutub, A. A., Mac Gabhann, F., Karagiannis, E. D., Vempati, P., and Popel, A. S. (2009). Multiscale models of angiogenesis. IEEE Eng. Med. Biol. Mag. 28,14-31.
42. Roberts, D. M., Kearney, J. B., Johnson, J. H., Rosenberg, M. P., Kumar, R., and Bautch, V. L. (2004). The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am.J. Pathol. 164, 1531-1535.
43. Robertson, S. H., Smith, C. K., Langhans, A. L., McLinden, S. E., Oberhardt, M. A., Jakab, K. R., Dzamba, B., DeSimone, D. W., Papin, J. A., and Peirce, S. M. (2007). Multiscale computational analysis of Xenopus laevis morphogenesis reveals key insights of systems-level behavior. BMC Syst. Biol. 1,46. doi: 10.1186/1752-0509-1-46
44. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., and Shima, D. T. (2002). Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16, 2684-2698.
45. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
46. Shibuya, M., and Claesson-Welsh, L. (2006). Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 312, 549-560.
47. Stalmans, I., Ng, Y. S., Rohan, R., Fruttiger, M., Bouché, A., Yuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S., Hicklin, D., Anderson, D J., Gardiner, T., Hammes, H. P., Moons, L., Dewerchin, M., Collen, D., Carmeliet, P., and D'Amore, P. A. (2002). Arteriolar and venular pat terning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109, 327-336.
48. Stokes, C. L., Lauffenburger, D. A., and Williams, S. K. (1991). Migration of individual microvessel endothelial cells: stochastic model and parameter measurement. J. Cell. Sci. 99(PT 2), 419-430.
49. Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M. P., Appelmans, S., Oh, H., Van Damme, P., Rutten, B., Man, W Y, De Mol, M., Wyns, S., Manka, D., Vermeulen, K., Van Den Bosch, L., Mertens, N., Schmitz, C., Robberecht, W., Conway, E. M., Collen, D., Moons, L., and Carmeliet, P. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8, 85-92.
50. Sun, S., Wheeler, M. F., Obeyesekere, M., and Patrick, C. W. Jr. (2005). A deterministic model of growth factor-induced angiogenesis. Bull. Math. Biol. 67, 313-337.
51. Tanaka, K., Yamaguchi, S., Sawano, A., and Shibuya, M. (1997). Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase). Jpn. J. Cancer Res. 88, 867-876.
52. Vempati, P., Mac Gabhann, F., and Popel, A. S. (2010). Quantifying the proteolytic release of extracellular matrixsequestered VEGF with a computational model. PLoS ONE 5, e1 1860. doi: 10.1371/journal.pone.00 11860
53. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C. H. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995.
54. Wu, F. T., Stefanini, M. O., Mac Gabhann, F., Kontos, C. D., Annex, B. H., and Popel, A. S. (2010a). A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J. Cell. Mol. Med. 14, 528-552.
55. Wu, F. T., Stefanini, M. O., Mac Gabhann, F., Kontos, C. D., Annex, B. H., and Popel, A. S. (2010b). VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. Am. J. Physiol. Heart Circ. Physiol. 298, H2174-H2191.
56. Zeng, G., and Bautch, V. L. (2009). Differentiation and dynamic analysis of primitive vessels from embryonic stem cells. Methods Mol. Biol. 482, 333-344.
57. Zeng, G., Taylor, S. M., McColm, J. R., Kappas, N. C., Kearney, J. B., Williams, L. H., Hartnett, M. E., and Bautch, V. L. (2007). Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood 109, 1345-1352.